Cargando…
Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2
A major challenge in the field of ligand discovery is to identify chemically useful fragments that can be developed into inhibitors of specific protein-protein interactions. Low molecular weight fragments (with molecular weight less than 250 Da) are likely to bind weakly to a protein’s surface. Here...
Autores principales: | Houston, Douglas R., Yen, Li-Hsuan, Pettit, Simon, Walkinshaw, Malcolm D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401541/ https://www.ncbi.nlm.nih.gov/pubmed/25884407 http://dx.doi.org/10.1371/journal.pone.0121424 |
Ejemplares similares
-
Elucidation of Ligand-Dependent Modulation of Disorder-Order Transitions in the Oncoprotein MDM2
por: Bueren-Calabuig, Juan A., et al.
Publicado: (2015) -
Discovery of a novel ligand that modulates the protein–protein interactions of the AAA+ superfamily oncoprotein reptin
por: Healy, Alan R., et al.
Publicado: (2015) -
Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents
por: Li, Bing-Hui, et al.
Publicado: (2021) -
Regulation of the Abundance of Kaposi’s Sarcoma-Associated Herpesvirus ORF50 Protein by Oncoprotein MDM2
por: Chang, Tzu-Hsuan, et al.
Publicado: (2016) -
Multiple chemical scaffolds inhibit a promising Leishmania drug target
por: Walkinshaw, Malcolm
Publicado: (2014)